Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin for postoperative anxiolysis and analgesia after vitreo-retinal surgery
IRCT20210117050057N1Phase 3Completed
- Sponsor
- Magrabi Hospitals & Centers
- Start
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postoperative pain and anxiety disorder comparing Pregabalin with Placebo (2 arms). Primary endpoint: Post-operative pain. Started Feb 2021; status: completed.
02
Drugs
pregabalin
03
Conditions
postoperative painanxiety disorder
Beyond the preview
Go deeper on IRCT20210117050057N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210117050057N1.